Epipen 300 µg inj. opl. i.m. voorgev. pen 2 ml
Active ingredient: Epinephrine
View notice details →
News topic
All current shortage notices related to Expected end: 2026-07, structured by product, country, active ingredient and reporting period.
15 noticesActive ingredient: Epinephrine
View notice details →Active ingredient: Iodixanol
View notice details →Active ingredient: Iodixanol
View notice details →Active ingredient: Levonorgestrel; Ethinylestradiol; Levonorgestrel; Ethinylestradiol; Levonorgestrel; Ethinylestradiol
View notice details →Active ingredient: Olmesartan Medoxomil; Amlodipine
View notice details →Active ingredient: Quetiapine
View notice details →Active ingredient: Quetiapine
View notice details →Active ingredient: Iohexol
View notice details →Active ingredient: Alglucosidase Alfa
View notice details →Active ingredient: Terbinafine
View notice details →Active ingredient: Iodine
View notice details →Active ingredient: Fenticonazole Nitrate
View notice details →Active ingredient: Fenticonazole Nitrate
View notice details →Active ingredient: Tetraxetan; Gadolinium Oxide; Gadoteric Acid
View notice details →Active ingredient: Clostridium Botulinum Toxin Type A
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →